InsidersTradesSigma
Track the 삼아제약 share price and the full management transaction log of the company, a listed issuer based in South Korea. Shares are quoted on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 삼아제약 has published 1 public disclosures. Market capitalisation: €74.6bn. The latest transaction was filed on 11 March 2026 (Other). Among the most active insiders: 삼아제약. The full history is openly available.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Samah Pharmaceutical is a South Korean pharmaceutical company focused on the development and manufacturing of medications. It is listed on the XKRX market.